Obesity medicine

GLP-1 Agonists Explained: Ozempic®/ Wegovy® (Semaglutide) vs. Mounjaro®/Zepbound™ (Tirzepatide)

1. Why GLP-1s Are Having a Moment Glucagon-like peptide-1 (GLP-1) receptor agonists lower appetite, slow gastric emptying, and boost insulin. Novo Nordisk’s Ozempic®/Wegovy® (semaglutide) mimics GLP-1 alone, while Lilly’s Mounjaro®/Zepbound™ (tirzepatide) hits both GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptors, making it a “dual incretin.” That extra target may explain its headline-grabbing results. (Wikipedia) 2.…

Two injectors dosing pens for anti-obesity medication and yellow measuring tape

What Are the Different Types of Weight Loss Injections?

With obesity affecting over 40% of American adults, medical science has advanced beyond traditional weight management approaches. Weight loss injections represent a significant breakthrough in obesity treatment, offering clinically proven results for those who haven’t succeeded through diet and exercise alone. These FDA-approved medications work by targeting specific hormonal pathways that control hunger and metabolism.…

Weight Loss Clinics

Are There Any Weight Loss Clinics in Miami?

Managing body weight effectively presents various challenges, from sticking to the right diet plans to maintaining consistent exercise routines. With a variety of factors affecting weight, many Miami residents search for expert guidance to achieve their weight loss goals. Fortunately, Miami hosts numerous medical weight loss clinics that provide comprehensive solutions tailored to individual needs,…

Semaglutide

The Role of Semaglutide in Alzheimer’s Disease: A New Frontier in Treatment?

Alzheimer’s disease, the most common form of dementia, affects millions of people worldwide, slowly erasing memories and cognitive abilities. While much research has focused on improving symptomatic treatment, researchers have increasingly explored drugs that may not only relieve symptoms but also target the disease’s underlying mechanisms. One such emerging candidate is semaglutide—a medication more commonly…

Exploring the Power of Semaglutide: A Game-Changer in the Treatment of Obesity

By Dimitri Gitelmaker, MD  Obesity has become a global health epidemic, affecting millions of people worldwide and posing significant health risks. Obesity in the United States affects 42% of adults and 20% of children, and accounts for approximately $147 billion in annual health care costs. Becoming overweight is the leading cause for developing prediabetes, and…

A Comparison of Weight Loss Medications: Topiramate, Bupropion, Naltrexone, Phentermine, and GLP1s

by Dimitri Gitelmaker, MD As a physician board certified in obesity management, I understand the importance of evidence-based information when it comes to prescribing medications for weight loss. In this blog post, I will provide a comprehensive comparison of five popular weight loss medications – topiramate, bupropion, naltrexone, phentermine, and GLP-1 agonists – supported by…